Good and bad amyloid antibodies

被引：12

作者：

Mattson, MP ^{[1
]}

Chan, SL ^{[1
]}

机构：

[1] NIA, Neurosci Lab, Baltimore, MD 21224 USA

来源：

SCIENCE | 2003年 / 301卷 / 5641期

关键词：

D O I：

10.1126/science.301.5641.1847

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

收藏

页码：1847 / 1849

页数：3

相关论文

共 12 条

[1] Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].

Bard, F ;

Cannon, C ;

Barbour, R ;

Burke, RL ;

Games, D ;

Grajeda, H ;

Guido, T ;

Hu, K ;

Huang, JP ;

Johnson-Wood, K ;

Khan, K ;

Kholodenko, D ;

Lee, M ;

Lieberburg, I ;

Motter, R ;

Nguyen, M ;

Soriano, F ;

Vasquez, N ;

Weiss, K ;

Welch, B ;

Seubert, P ;

Schenk, D ;

Yednock, T .

NATURE MEDICINE, 2000, 6 (08) :916-919

[2] Alzheimer disease's double-edged vaccine [J].

Greenberg, SM ;

Bacskai, BJ ;

Hyman, BT .

NATURE MEDICINE, 2003, 9 (04) :389-390

[3] A MODEL FOR BETA-AMYLOID AGGREGATION AND NEUROTOXICITY BASED ON FREE-RADICAL GENERATION BY THE PEPTIDE - RELEVANCE TO ALZHEIMER-DISEASE [J].

HENSLEY, K ;

CARNEY, JM ;

MATTSON, MP ;

AKSENOVA, M ;

HARRIS, M ;

WU, JF ;

FLOYD, RA ;

BUTTERFIELD, DA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3270-3274

[4] Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease [J].

Hock, C ;

Konietzko, U ;

Streffer, JR ;

Tracy, J ;

Signorell, A ;

Müller-Tillmanns, B ;

Lemke, U ;

Henke, K ;

Moritz, E ;

Garcia, E ;

Wollmer, MA ;

Umbricht, D ;

de Quervain, DJF ;

Hofmann, M ;

Maddalena, A ;

Papassotiropoulos, A ;

Nitsch, RM .

NEURON, 2003, 38 (04) :547-554

[5] Cu(II) potentiation of Alzheimer Aβ neurotoxicity -: Correlation with cell-free hydrogen peroxide production and metal reduction [J].

Huang, XD ;

Cuajungco, MP ;

Atwood, CS ;

Hartshorn, MA ;

Tyndall, JDA ;

Hanson, GR ;

Stokes, KC ;

Leopold, M ;

Multhaup, G ;

Goldstein, LE ;

Scarpa, RC ;

Saunders, AJ ;

Lim, J ;

Moir, RD ;

Glabe, C ;

Bowden, EF ;

Masters, CL ;

Fairlie, DP ;

Tanzi, RE ;

Bush, AI .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (52) :37111-37116

[6] Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum? [J].

Klein, WL ;

Krafft, GA ;

Finch, CE .

TRENDS IN NEUROSCIENCES, 2001, 24 (04) :219-224

[7]

Mark RJ, 1997, J NEUROSCI, V17, P1046

[8] Autoantibodies to amyloid β-peptide (Aβ) are increased in Alzheimer's disease patients and Aβ antibodies can enhance Aβ neurotoxicity -: Implications for disease pathogenesis and vaccine development [J].

Nath, A ;

Hall, E ;

Tuzova, M ;

Dobbs, M ;

Jones, M ;

Anderson, C ;

Woodward, J ;

Guo, ZH ;

Fu, WM ;

Kryscio, R ;

Wekstein, D ;

Smith, C ;

Markesbery, WR ;

Mattson, MP .

NEUROMOLECULAR MEDICINE, 2003, 3 (01) :29-39

[9] Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse [J].

Schenk, D ;

Barbour, R ;

Dunn, W ;

Gordon, G ;

Grajeda, H ;

Guido, T ;

Hu, K ;

Huang, JP ;

Johnson-Wood, K ;

Khan, K ;

Kholodenko, D ;

Lee, M ;

Liao, ZM ;

Lieberburg, I ;

Motter, R ;

Mutter, L ;

Soriano, F ;

Shopp, G ;

Vasquez, N ;

Vandevert, C ;

Walker, S ;

Wogulis, M ;

Yednock, T ;

Games, D ;

Seubert, P .

NATURE, 1999, 400 (6740) :173-177

[10] Development of a novel diffusion-based method to estimate the size of the aggregated Aβ species responsible for neurotoxicity [J].

Wang, SSS ;

Becerra-Arteaga, A ;

Good, TA .

BIOTECHNOLOGY AND BIOENGINEERING, 2002, 80 (01) :50-59